Baidu
map

The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets

Awada, C; Boucherat, O; Provencher, S; Bonnet, S; Potus, F

Potus, F (通讯作者),Inst Univ Cardiol & Pneumol Quebec, Pulm Hypertens Res Grp, Ctr Rech, 2725 Chemin Sainte Foy, Quebec City, PQ G1V 4G5, Canada.

VASCULAR PHARMACOLOGY, 2023; 151 ():

Abstract

Pulmonary hypertension due to left heart disease (PH-LHD) or group 2 PH is the most common and lethal form of PH, occurring secondary to left ventricu......

Full Text Link


Baidu
map
Baidu
map
Baidu
map